TEMOZOLOMIDE

Formula & Concentration

TEMOZOLOMIDE- temozolomide capsule

Manufacturer

Devatis Inc.

Indications

TEMOZOLOMIDE Capsules are an alkylating drug indicated for the treatment of adult patients with:

Newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. (1.1)
Anaplastic astrocytoma (1.2)
Adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma. (1.2)
Treatment of adults with refractory anaplastic astrocytoma. (1.2)

Product Options

Package Size

NDC #

Presentation

5 mg

73043-0011-14

Cap

20 mg

73043-0012-05

Cap

20 mg

73043-0012-14

Cap

100 mg

73043-0013-05

Cap

100 mg

73043-0013-14

Cap

140 mg

73043-0014-05

Cap

140 mg

73043-0014-14

Cap

180 mg

73043-0015-05

Cap

250 mg

73043-0016-05

Cap

Shelf Life and Storage

Store TEMOZOLOMIDE Capsules, USP at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].